Neurodevelopmental Outcomes From the PREVeNT Trial.

Saved in:
Bibliographic Details
Title: Neurodevelopmental Outcomes From the PREVeNT Trial.
Authors: O'Kelley SE; Departments of Psychology and Pediatrics, University of Alabama at Birmingham, Birmingham, Alabama. Electronic address: sokelley@uab.edu., Capal JK; Department of Neurology, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina; Division of Neurology, Department of Pediatrics, Cincinnati Children's Hospital Medical Center, University of Cincinnati College of Medicine, Cincinnati, Ohio., McPherson TO; Department of Biostatistics and Bioinformatics, Emory University, Atlanta, Georgia., Patrick KE; Department of Neurology, University of Washington School of Medicine, Seattle, Washington; Department of Neurosciences, Seattle Children's Hospital, Seattle, Washington., Pearson DA; Louis A. Faillace, MD Department of Psychiatry and Behavioral Sciences, McGovern Medical School, The University of Texas Health Science Center at Houston (UT Health), Houston, Texas., Davis PE; Department of Neurology, Boston Children's Hospital, Harvard Medical School, Boston, Massachusetts., Currans K; Division of Behavior Medicine and Clinical Psychology, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio., Byars AW; Division of Neurology, Department of Pediatrics, Cincinnati Children's Hospital Medical Center, University of Cincinnati College of Medicine, Cincinnati, Ohio., Porter BE; Department of Neurology, Stanford University, Stanford, California., Sahin M; Department of Neurology, Boston Children's Hospital, Harvard Medical School, Boston, Massachusetts; Rosamund Stone Zander Translational Neuroscience Center, Boston Children's Hospital, Boston, Massachusetts., Taub KS; Department of Pediatrics, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania., Rajaraman R; Department of Pediatrics and Psychiatry and Biobehavioral Sciences, University of California, Los Angeles, Los Angeles, California., Randle S; Department of Neurology, University of Washington School of Medicine, Seattle, Washington; Department of Neurosciences, Seattle Children's Hospital, Seattle, Washington., McClintock WM; Division of Neurology, Department of Pediatrics, Children's National Medical Center, Washington, District of Columbia., Koenig MK; Department of Pediatrics, McGovern Medical School at the University of Texas Health Science Center at Houston (UTHealth Houston), Children's Memorial Hermann Hospital, Houston, Texas., Frost MD; Minnesota Epilepsy Group, P.A., Minnesota Epilepsy Group, Roseville, Minnesota., Werner K; Department of Pediatrics, Duke University, Durham, North Carolina., Nolan DA; Pediatric Epilepsy Division, Department of Pediatrics, Corewell Health William Beaumont Children's, Royal Oak, Michigan., Wong M; Department of Neurology, Washington University in Saint Louis, Saint Louis, Missouri., Krefting JL; Department of Neurology, University of Alabama at Birmingham, Birmingham, Alabama., Cutter GR; Department of Biostatistics, University of Alabama at Birmingham, Birmingham, Alabama., Krueger DA; Division of Neurology, Department of Pediatrics, Cincinnati Children's Hospital Medical Center, University of Cincinnati College of Medicine, Cincinnati, Ohio., Bebin EM; Departments of Neurology and Pediatrics, University of Alabama at Birmingham, Birmingham, Alabama.
Corporate Authors: PREVeNT Study Group
Source: Pediatric neurology [Pediatr Neurol] 2025 Dec; Vol. 173, pp. 88-97. Date of Electronic Publication: 2025 Sep 16.
Publication Type: Journal Article; Multicenter Study; Clinical Trial, Phase II; Randomized Controlled Trial
Journal Info: Publisher: Elsevier Science Publishing Country of Publication: United States NLM ID: 8508183 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1873-5150 (Electronic) Linking ISSN: 08878994 NLM ISO Abbreviation: Pediatr Neurol Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1873-5150
DOI:10.1016/j.pediatrneurol.2025.09.006